Remote Jobs at GondolaBio

GondolaBio

11 - 50 employees

Founded 2024

🧬 Biotechnology

💊 Pharmaceuticals

💰 $300M Venture Round - GondolaBio on 2024-08

Biotechnology • Pharmaceuticals

GondolaBio is a clinical-stage biopharmaceutical company launched in 2024 and affiliated with BridgeBio Pharma, focused on developing breakthrough therapeutics for patients with genetic diseases. The company uses a lean, decentralized approach to accelerate early-stage research and development across multiple modalities (including small molecules and oligonucleotide therapies) and is building a diverse pipeline targeting rare and underserved genetic conditions such as EPP/XLP with its lead program PORT-77. GondolaBio centers patient needs and aims to bring disease-modifying treatments more quickly to populations lacking approved therapies.